Corporate News: MeVis publishes figures for the first nine months of fiscal 2018/2019

Slight increase in revenues with stable costs


Revenues at € 4.4 million approximately 12 % above previous year's level

EBIT of € 5.4 million in the first nine months (previous year: € 4.4 Million)

EBIT margin increased slightly to 43 % (previous year: 37 %)

Profit after tax of € 5.8 million (previous year: € 5.1 million)  

Bremen, August 29, 2019 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, announces the results for the third quarter and first nine months of fiscal year 2018/2019 (reporting period October 1, 2018 to June 30, 2019).

Revenues in the third quarter of fiscal year 2018/2019 amounted to € 4,350 k, about 12 % above the previous year's level (€ 3,900 k). License business increased by 25 % in the third quarter to € 1,239 k (prev. year: € 995 k), and the maintenance business by 12 % to € 1,822 k (prev. year: € 1,632 k) compared to the previous year"s period. The service business increased from € 1,270 k in the previous year's period to € 1,289 k.

Revenues in the first nine months thus amounted to € 12,594 k (prev. year: € 12,133 k) and were allocated to the segments Digital Mammography with € 7,135 k (prev. year: € 8,192 k), Development Services with € 3,060 k (prev. year: € 1,583 k) and Other Operating Activities with € 2,399 k (prev. year: € 2,358 k). With a share of 57 % (prev. year: 68 %), the Digital Mammography segment continued to be the main source of revenues.

EBIT (Earnings before financial result and taxes) amounted to € 5,376 k in the reporting period (prev. year: € 4,440 k). At 43 %, the EBIT margin improved compared with a previous year's value of 37 %.

The financial result declined significantly in the reporting period to € 390 k (prev. year: € 685 k). The change compared with the previous year is due to the development of the balance of income and expenses from exchange rate differences of € 494 k (prev. year: € 120 k) and the deterioration in the result of the 51 % share in MeVis BreastCare GmbH & Co. KG of € -216 k (prev. year: € 461 k), which is recognized at equity and interest income in the amount of € 127 k (prev. year: € 117 k).

Net profit after taxes therefore amounted to € 5,766 k (prev. year: € 5,122 k), corresponding with undiluted earnings per share of € 3.17 (prev. year: € 2.81).